etravirine has been researched along with Mood Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, TB; Girard, PM; Grinsztejn, B; Hartikainen, J; Nijs, S; Rachline, A; Witek, J | 1 |
| Berger, DS; Blick, G; Cimoch, PJ; Cohen, CJ; Greenberg, RN; Hicks, CB; Hoetelmans, RM; Iveson, KJ; Jayaweera, DS; Mills, AM; Nadler, JP; Peeters, MP; Ruane, PJ; Schrader, SR; Shalit, P; Smith, SM; Steinhart, CR; Thompson, M; Vingerhoets, JH; Voorspoels, E; Ward, D; Woodfall, B | 1 |
2 trial(s) available for etravirine and Mood Disorders
| Article | Year |
|---|---|
Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest.
Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Dizziness; Double-Blind Method; Exanthema; Female; Headache; Humans; Male; Middle Aged; Mood Disorders; Nitriles; Pyridazines; Pyrimidines; Sleep Wake Disorders; Viral Load | 2012 |
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
Topics: Adult; CD4 Lymphocyte Count; Dreams; Drug Administration Schedule; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Mood Disorders; Mutation; Nitriles; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load | 2007 |